Literature DB >> 12055605

Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice.

Hubert Louis1, Alain Le Moine, Véronique Flamand, Nathalie Nagy, Eric Quertinmont, Frédéric Paulart, Daniel Abramowicz, Olivier Le Moine, Michel Goldman, Jacques Devière.   

Abstract

BACKGROUND & AIMS: Eosinophils are observed in several liver diseases, but their contribution in the pathogenesis of these disorders remains poorly investigated. Concanavalin A (Con A)-induced hepatitis is an experimental model of immune-mediated liver injury in which natural killer T (NKT) cells play a critical role through the production of interleukin (IL)-4 and the expression of Fas ligand (FasL). Because activated NKT cells also produce IL-5, a critical cytokine for eosinophil maturation and function, the role of IL-5 was investigated in this model.
METHODS: IL-5-deficient mice, eosinophil depletion in wild-type (WT) mice, and NKT cell transfer from WT- or IL-5-deficient mice into NKT cell-deficient mice were used to assess the role of IL-5 and eosinophils.
RESULTS: Liver eosinophil infiltrate and IL-5 production were observed after Con A challenge. Liver injury was dramatically reduced in IL-5-deficient or eosinophil-depleted mice. In addition, residual hepatitis observed in Fas-deficient mice was abolished after IL-5 neutralization. Finally, we showed that NKT cells constituted a critical source of IL-5. Indeed, transfer of WT NKT cells to mice lacking NKT cells restored liver injury, whereas transfer of IL-5-deficient NKT cells did not.
CONCLUSIONS: These observations highlight the pathologic role of IL-5 and eosinophils in experimental immune-mediated hepatitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12055605     DOI: 10.1053/gast.2002.33620

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  17 in total

1.  Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors.

Authors:  Cynthia A Ellison; Masaru Taniguchi; Jacqie M M Fischer; Kent T Hayglass; John G Gartner
Journal:  Immunology       Date:  2006-07-26       Impact factor: 7.397

2.  Retinoic acid modulates interferon-γ production by hepatic natural killer T cells via phosphatase 2A and the extracellular signal-regulated kinase pathway.

Authors:  Heng-Kwei Chang; Wu-Shiun Hou
Journal:  J Interferon Cytokine Res       Date:  2014-10-24       Impact factor: 2.607

3.  Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice.

Authors:  William R Proctor; Mala Chakraborty; Lynette S Chea; Jeffrey C Morrison; Julia D Berkson; Kenrick Semple; Mohammed Bourdi; Lance R Pohl
Journal:  Hepatology       Date:  2013-03-15       Impact factor: 17.425

4.  Eosinophils attenuate hepatic ischemia-reperfusion injury in mice through ST2-dependent IL-13 production.

Authors:  Yaochun Wang; Yang Yang; Meng Wang; Shuhong Wang; Jong-Min Jeong; Long Xu; Yankai Wen; Christoph Emontzpohl; Constance Lynn Atkins; Kevin Duong; Nicolas F Moreno; Xiaoyi Yuan; David R Hall; Wasim Dar; Dechun Feng; Bin Gao; Yong Xu; Zoltan Czigany; Sean P Colgan; J Steve Bynon; Shizuo Akira; Jared M Brown; Holger K Eltzschig; Elizabeth A Jacobsen; Cynthia Ju
Journal:  Sci Transl Med       Date:  2021-02-03       Impact factor: 17.956

5.  Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells.

Authors:  Venkatesh L Hegde; Shweta Hegde; Benjamin F Cravatt; Lorne J Hofseth; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Mol Pharmacol       Date:  2008-04-03       Impact factor: 4.436

6.  Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-γ production in mice.

Authors:  Jie Chen; Lihua Duan; Ali Xiong; Hongwei Zhang; Fang Zheng; Zheng Tan; Feili Gong; Min Fang
Journal:  J Mol Med (Berl)       Date:  2012-09-16       Impact factor: 4.599

7.  IP-10 protects while MIP-2 promotes experimental anesthetic hapten - induced hepatitis.

Authors:  Dolores B Njoku; Zhaoxia Li; Jenelle L Mellerson; Rajni Sharma; Monica V Talor; Nicole Barat; Noel R Rose
Journal:  J Autoimmun       Date:  2009-01-07       Impact factor: 7.094

Review 8.  Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis.

Authors:  Rupal Pandey; Venkatesh L Hegde; Narendra P Singh; Lorne Hofseth; Uday Singh; Swapan Ray; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  Vitam Horm       Date:  2009       Impact factor: 3.421

9.  Thymic stromal lymphopoietin and interleukin-4 mediate the pathogenesis of halothane-induced liver injury in mice.

Authors:  William R Proctor; Mala Chakraborty; Aaron M Fullerton; Midhun C Korrapati; Pauline M Ryan; Kenrick Semple; Jeffrey C Morrison; Julia D Berkson; Lynette S Chea; Qian Yang; Albert P Li; Rosanne Spolski; Erin E West; Yrina Rochman; Warren J Leonard; Mohammed Bourdi; Lance R Pohl
Journal:  Hepatology       Date:  2014-05-20       Impact factor: 17.425

10.  Myeloid STAT3 inhibits T cell-mediated hepatitis by regulating T helper 1 cytokine and interleukin-17 production.

Authors:  Fouad Lafdil; Hua Wang; Ogyi Park; Weici Zhang; Yuki Moritoki; Shi Yin; Xin Yuan Fu; M Eric Gershwin; Zhe-Xiong Lian; Bin Gao
Journal:  Gastroenterology       Date:  2009-08-15       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.